Cardiac Biotech Solutions (CBSC) Enterprise Value: 5.724M

Cardiac Biotech Solutions, Inc. (CBSC)

0.0305 0.00 (0.00%) USD | OTCM | Oct 30, 16:00

Enterprise Value Chart

Historical Enterprise Value Data

View and export this data back to 2016. Start Trial.

Date	Value
October 30, 2026	5.724M
October 29, 2026	5.690M
October 28, 2026	5.690M
October 27, 2026	5.690M
October 26, 2026	5.690M
October 23, 2026	6.099M
October 22, 2026	6.099M
October 21, 2026	6.099M
October 20, 2026	6.099M
October 19, 2026	6.579M
October 16, 2026	6.579M
October 15, 2026	6.579M
October 14, 2026	6.579M
October 13, 2026	6.579M
October 12, 2026	6.491M
October 09, 2026	6.491M
October 08, 2026	6.491M
October 07, 2026	6.491M
October 06, 2026	6.491M
October 05, 2026	6.491M
October 02, 2026	6.491M
October 01, 2026	6.491M
September 30, 2026	6.491M
September 29, 2026	5.886M
September 28, 2026	5.886M

Date	Value
September 25, 2026	5.886M
September 24, 2026	5.886M
September 23, 2026	5.886M
September 22, 2026	6.729M
September 21, 2026	6.729M
September 18, 2026	6.729M
September 17, 2026	6.729M
September 16, 2026	6.729M
September 15, 2026	6.729M
September 14, 2026	6.576M
September 11, 2026	6.576M
September 10, 2026	6.576M
September 09, 2026	6.576M
September 08, 2026	6.588M
September 04, 2026	6.588M
September 03, 2026	6.588M
September 02, 2026	6.588M
September 01, 2026	7.326M
August 31, 2026	7.343M
August 28, 2026	7.343M
August 27, 2026	7.343M
August 26, 2026	7.343M
August 25, 2026	7.343M
August 24, 2026	7.343M
August 21, 2026	7.002M

Enterprise Value Definition

EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.

Read full definition.

Enterprise Value Range, Past 5 Years

View Enterprise Value Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

Enterprise Value Benchmarks

View Enterprise Value Benchmarks